James Shearer - Concepedia

Author

James Shearer

King's College London ORCID

Also Known As

J Shearer, J. D. Shearer, J. Shearer, JAMES SHEARER, James Shearer, Mark Lovell

122

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

King's College London UNSW Sydney South London and Maudsley NHS Foundation Trust University of Exeter University College London

About

James Shearer is an author at King's College London specializing in medicine, psychiatry, and substance abuse.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	684
2	Health Sciences	8	8	217
3	Education	2	2	57
4	Engineering	1	1	107
5	Nursing	1	1	12

James Shearer

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Four‐year follow‐up of imprisoned male heroin users and methadone treatment: mortality, re‐incarceration and hepatitis C infection Kate Dolan, James Shearer, Bethany White, Addiction	2005	245
A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system Kate Dolan, James Shearer, Margaret MacDonald, Drug and Alcohol Dependence Substance AbuseSubstance UsePsychiatryHealth PolicyAddiction	2003	204
A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence James Shearer, Shane Darke, Craig Rodgers, Addiction	2009	154
Pilot randomized double blind placebo‐controlled study of dexamphetamine for cocaine dependence James Shearer, Alex Wodak, Ingrid van Beek, Addiction	2003	142
Machine Learning-Based Method for Personalized and Cost-Effective Detection of Alzheimer's Disease Javier Escudero, Emmanuel Ifeachor, John Zajicek, IEEE Transactions on Biomedical Engineering EngineeringMachine LearningIntelligent DiagnosticsMachine Learning ApproachDiagnosis	2012	107
The First Episode Rapid Early Intervention for Eating Disorders ‐ Upscaled study: Clinical outcomes Amelia Austin, Michaela Flynn, James Shearer, Early Intervention in Psychiatry	2021	96
Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence James Shearer, Alex Wodak, Richard P. Mattick, Addiction	2001	93
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis Susan Ball, Jane Vickery, Jeremy Hobart, Health Technology Assessment	2015	70
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson’s disease James Shearer, Colin Green, Carl Counsell, Journal of Neurology Motor DysfunctionNeurological DisorderMedicineParkinson DiseaseHealth State Values	2011	54
Evaluation of the Condom Distribution Program in New South Wales Prisons, Australia Kate Dolan, David Lowe, James Shearer The Journal of Law Medicine & Ethics HomosexualityCondom Distribution ProgramHarm ReductionSocial SciencesContraception	2004	46

Page 1